# A Study of GWP42006 in People With Focal Seizures - Part B

> **NCT02365610** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 162 (actual)

## Conditions studied

- Epilepsy
- Focal Seizures

## Interventions

- **DRUG:** GWP42006
- **DRUG:** Placebo Control

## Key facts

- **NCT ID:** NCT02365610
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-07
- **Final completion:** 2017-09
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365610, "A Study of GWP42006 in People With Focal Seizures - Part B". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02365610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*